Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
Status:
Terminated
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate whether, in a standardised cohort of patients with mild to
moderate PTS, monitored for a sufficiently long follow-up period, quality of life measured by
generic instruments and disease-specific instruments evolves favourably in this patient
profile.
Study objective: to evaluate the evolution of quality of life in general and in the specific
context of the disease of patients who have experienced an episode of deep-vein thrombosis
(DVT), are affected by post-thrombotic syndrome, are subject to compression therapy and
receive an additional standard venoactive agent (sulodexide 15 mg twice daily during 6
months).